Tags

Type your tag names separated by a space and hit enter

The first genome-wide view of vitamin D receptor locations and their mechanistic implications.
Anticancer Res 2012; 32(1):271-82AR

Abstract

The transcription factor vitamin D receptor (VDR) is the nuclear sensor for the biologically most active metabolite of vitamin D, 1α,25-dihydroxyvitamin D(3) (1α,25(OH)(2)D(3)). The physiological actions of the VDR and its ligand are not only the well-known regulation of calcium and phosphorus uptake and transport controlling bone formation, but also their significant involvement in the control of immune functions and of cellular growth and differentiation. For a general understanding of the mechanisms of 1α,25(OH)(2)D(3) signaling, it is essential to monitor the genome-wide location of VDR in relation to primary 1α,25(OH)(2)D(3) target genes. Within the last months, two chromatin immunoprecipitation sequencing (ChIP-Seq) studies using cells of the hematopoietic system, lymphoblastoids and monocytes, were published. The reports indicated the existence of 2776 and 1820 1α,25(OH)(2)D(3)-stimulated VDR-binding sites, comparable numbers, of which, however, only 18.2% overlapped. The two studies were very different in their 1α,25(OH)(2)D(3) treatment times (36 h versus 40 min), but showed consensus in identifying response elements formed by a direct repeat of two hexameric binding sites with three intervening nucleotide (DR3) as major DNA contact sites of the VDR. Interestingly, when analyzed in the same way, both reports indicated that within 100 bp of their VDR ChIP-Seq peak summits only fewer than 40% contain a DR3-type response element. This review provides a detailed comparison of the insights obtained from both ChIP-Seq studies.

Authors+Show Affiliations

Department of Biosciences, University of Eastern Finland, P.O. Box 1627, FIN-70211 Kuopio, Finland. carsten.carlberg@uef.fiNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't
Review

Language

eng

PubMed ID

22213316

Citation

Carlberg, Carsten, et al. "The First Genome-wide View of Vitamin D Receptor Locations and Their Mechanistic Implications." Anticancer Research, vol. 32, no. 1, 2012, pp. 271-82.
Carlberg C, Seuter S, Heikkinen S. The first genome-wide view of vitamin D receptor locations and their mechanistic implications. Anticancer Res. 2012;32(1):271-82.
Carlberg, C., Seuter, S., & Heikkinen, S. (2012). The first genome-wide view of vitamin D receptor locations and their mechanistic implications. Anticancer Research, 32(1), pp. 271-82.
Carlberg C, Seuter S, Heikkinen S. The First Genome-wide View of Vitamin D Receptor Locations and Their Mechanistic Implications. Anticancer Res. 2012;32(1):271-82. PubMed PMID: 22213316.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The first genome-wide view of vitamin D receptor locations and their mechanistic implications. AU - Carlberg,Carsten, AU - Seuter,Sabine, AU - Heikkinen,Sami, PY - 2012/1/4/entrez PY - 2012/1/4/pubmed PY - 2012/3/1/medline SP - 271 EP - 82 JF - Anticancer research JO - Anticancer Res. VL - 32 IS - 1 N2 - The transcription factor vitamin D receptor (VDR) is the nuclear sensor for the biologically most active metabolite of vitamin D, 1α,25-dihydroxyvitamin D(3) (1α,25(OH)(2)D(3)). The physiological actions of the VDR and its ligand are not only the well-known regulation of calcium and phosphorus uptake and transport controlling bone formation, but also their significant involvement in the control of immune functions and of cellular growth and differentiation. For a general understanding of the mechanisms of 1α,25(OH)(2)D(3) signaling, it is essential to monitor the genome-wide location of VDR in relation to primary 1α,25(OH)(2)D(3) target genes. Within the last months, two chromatin immunoprecipitation sequencing (ChIP-Seq) studies using cells of the hematopoietic system, lymphoblastoids and monocytes, were published. The reports indicated the existence of 2776 and 1820 1α,25(OH)(2)D(3)-stimulated VDR-binding sites, comparable numbers, of which, however, only 18.2% overlapped. The two studies were very different in their 1α,25(OH)(2)D(3) treatment times (36 h versus 40 min), but showed consensus in identifying response elements formed by a direct repeat of two hexameric binding sites with three intervening nucleotide (DR3) as major DNA contact sites of the VDR. Interestingly, when analyzed in the same way, both reports indicated that within 100 bp of their VDR ChIP-Seq peak summits only fewer than 40% contain a DR3-type response element. This review provides a detailed comparison of the insights obtained from both ChIP-Seq studies. SN - 1791-7530 UR - https://www.unboundmedicine.com/medline/citation/22213316/The_first_genome_wide_view_of_vitamin_D_receptor_locations_and_their_mechanistic_implications_ L2 - http://ar.iiarjournals.org/cgi/pmidlookup?view=long&pmid=22213316 DB - PRIME DP - Unbound Medicine ER -